Australia markets open in 2 hours 57 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.36+0.37 (+7.41%)
At close: 04:00PM EDT
5.10 -0.26 (-4.85%)
After hours: 04:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 120.78M
Enterprise value 94.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.82
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.94

Trading information

Stock price history

Beta (5Y monthly) 2.14
52-week change 3-52.07%
S&P500 52-week change 3-5.66%
52-week high 312.28
52-week low 33.60
50-day moving average 35.78
200-day moving average 37.04

Share statistics

Avg vol (3-month) 3133.51k
Avg vol (10-day) 3143.92k
Shares outstanding 525.37M
Implied shares outstanding 6N/A
Float 821.6M
% held by insiders 114.85%
% held by institutions 116.96%
Shares short (28 Apr 2022) 4715.33k
Short ratio (28 Apr 2022) 45.73
Short % of float (28 Apr 2022) 43.00%
Short % of shares outstanding (28 Apr 2022) 42.82%
Shares short (prior month 30 Mar 2022) 41.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-24,623.27%

Management effectiveness

Return on assets (ttm)-42.47%
Return on equity (ttm)-69.71%

Income statement

Revenue (ttm)131.28k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)177.30%
Gross profit (ttm)-21.21M
EBITDA -32.14M
Net income avi to common (ttm)-31.76M
Diluted EPS (ttm)-1.25
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.41M
Total cash per share (mrq)1.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)14.35
Book value per share (mrq)1.25

Cash flow statement

Operating cash flow (ttm)-31.21M
Levered free cash flow (ttm)-19.86M